Quisisana Hospital, Ferrara.
Acta Biomed. 2021 Sep 2;92(4):e2021410. doi: 10.23750/abm.v92i4.11927.
Starting from 2021, Acta Biomedica Parmensis will dedicate an annual update to the "Advances in Hemoglobinopathies". The section editor of this new editorial initiative is prof. Ashraf T Soliman, Pediatrician and Endocrinologist at Hamad Medical Center (HMC) of Doha. Prof Soliman is a pionier in the study of endocrine complications in hemoglobinopathies and effects of blood transfusions on spermatogenesis. He collaborates strictly with prof. Mohamed Yassin, Hematologist-Oncologist at MCH and the International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescence Medicine (ICET-A). This issue of Acta Biomedica contains three articles on: The different patterns of insulin response during Oral Glucose Tolerance Test (OGTT) in transfused young patients with β- Thalassemia; Immigration and screening programs for hemoglobinopathies in Italy, Spain and Turkey and The effects of treatment with blood transfusion, iron chelation and hydroxyurea on puberty, growth and spermatogenesis in sickle cell disease,.
自 2021 年起,《帕多瓦生物医学学报》将专门为“血红蛋白病的进展”出版年度增刊。这一新编辑举措的章节编辑是多哈哈马德医疗中心的儿科医生和内分泌学家 Ashraf T Soliman 教授。Soliman 教授是研究血红蛋白病内分泌并发症和输血对精子发生影响的先驱。他与 Mohamed Yassin 教授密切合作,后者是 MCH 的血液学家-肿瘤学家,也是地中海贫血和青少年医学内分泌疾病国际临床医生网络 (ICET-A) 的成员。本期《帕多瓦生物医学学报》包含三篇文章,分别是:接受输血的年轻β-地中海贫血患者口服葡萄糖耐量试验(OGTT)期间不同的胰岛素反应模式;意大利、西班牙和土耳其的血红蛋白病移民和筛查计划;输血、铁螯合和羟基脲治疗对镰状细胞病青春期、生长和精子发生的影响。